<DOC>
	<DOCNO>NCT02032537</DOCNO>
	<brief_summary>Uraemic pruritus ( UP ) remain frequent distress problem patient advance chronic kidney disease ( CKD ) end-stage renal disease ( ESRD ) . Calmmax new topical cream introduce recently Calmmax Pharma , Israeli pharmaceutical company develop topical cream base active plant extract treatment skin inflammation . We intend conduct prospective , double blind , placebo control , randomize trial ass therapeutic effect Calmmax cream UP cohort CKD ESRD patient .</brief_summary>
	<brief_title>Efficacy Calmmax Cream Management Chronic Uremic Pruritus</brief_title>
	<detailed_description />
	<criteria>1 . History pruritus &gt; 8 week duration . 2 . Severity score pruritus â‰¥5 define VAS 3 . Discontinuation medication presume antipruritic effect least 1 week study ( include Calmmax cream ) 4 . Negative pregnancy test result participate woman childbearing age ; 1 . Known allergy Calmmax cream 2 . Any acute illness 3 . Liver cirrhosis 4 . Active dermatological disorder UP 5 . Decompensated heart failure 6 . Inability give inform consent 7 . Known poor adherence medical recommendation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>callmax cream</keyword>
	<keyword>uremic pruritus</keyword>
</DOC>